OSCR

Gut-initiated alpha synuclein fibrils drive parkinsonism phenotypes: temporal mapping of REM sleep behavior disorder-like and other non-motor symptoms.

Overview

  1. Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden
  2. Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD 20815 USA
  3. Department of Neurological Surgery, Weill Cornell Medicine, New York, NY USA
  4. Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD USA
  5. Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD USA
  6. Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205 USA
  7. Solomon H. Snyder Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD USA
  8. Department of Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD USA
Institutions: Karolinska Institutet (Sweden); Aligning Science Across Parkinson's (United States); Weill Cornell Medicine (United States); Johns Hopkins University (United States); Johns Hopkins Medicine (United States)
Journal: Translational neurodegeneration, volume 15, issue 1, article 10
Dates: received 30 July 2025; accepted 8 January 2026; published online 10 March 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1186/s40035-026-00536-6 · PMID 41808195 · PMCID PMC12973632 · OpenAlex W7134932499
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: mouse (organism), Parkinson's (population), sleep disorders (population), clinical / translational (subfield)
Methods: Spectral & time-frequency, Connectivity, Statistics, Preprocessing, fMRI & imaging, Physiology & signal measures
Keywords: Parkinson’s disease, Alpha-synuclein, Gut-brain axis, REM sleep behavior disorder, Dopamine
MeSH: alpha-Synuclein*, Brain*, Parkinsonian Disorders*, REM Sleep Behavior Disorder*, Animals, Disease Models, Animal, Male, Mice, Mice, Inbred C57BL, Phenotype (* major topic)
Topic: Parkinson's Disease Mechanisms and Treatments (Neurology, Medicine), according to OpenAlex
Funding: Aligning Science Across Parkinson's (020608); Karolinska Institute; Aligning Science Across Parkinson's (020608)
Citations: cited by 1 paper (Europe PMC); 84 references in the paper
Research resources: Wild-type C57BL/6 mice RRID:ISMR_JAX:000664, RRID:SCR_000306, RRID:SCR_000441, RRID:SCR_003070

Abstract

Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder marked by both motor and non-motor symptoms. Although non-motor features such as gastrointestinal and sleep disturbances often precede motor impairments and are critical to PD pathogenesis, the mechanisms underlying their onset and progression remain insufficiently characterized.

Methods: To investigate the sequential development of motor and non-motor symptoms in a model of experimental parkinsonism, we injected alpha-synuclein (αSyn) preformed fibrils (PFFs) into the duodenum and antrum of wild-type mice, establishing a gut-brain axis model of PD. We performed whole-brain anatomical mapping of αSyn-PFF propagation and assessed behavioral alterations at multiple time points post-injection. Correlations between anatomical spread and behavioral changes, particularly sleep, were further validated through SNCA overexpression or local αSyn-PFF injections in the substantia nigra, combined with dual-wavelength fiber photometry, behavioral assays, and histological analyses.

Results: Injection of αSyn-PFFs into the gastrointestinal tract of wild-type mice led to a progressive spread of pathological αSyn throughout the central nervous system, in temporal association with distinct motor and non-motor phenotypes. These findings provide translational validity of the gut-brain model, mirroring the clinical progression seen in many PD patients. In two established αSyn-based PD models, dual-wavelength fiber photometry that monitors dopamine and acetylcholine release in the striatum, demonstrated a central role for dopamine dysfunction in modulating sleep architecture, particularly in relation to REM sleep without atonia, consistent with REM sleep behavior disorder (RBD)-like manifestations in PD.

Conclusion: This work provides a detailed characterization of the progressive and multisystem nature of experimental parkinsonism, highlighting the interplay between αSyn pathology, gut-brain signaling, and the onset of non-motor disturbances, with a particular focus on RBD-like alterations in sleep.

Supplementary Information: The online version contains supplementary material available at 10.1186/s40035-026-00536-6.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data sharing

Detailed protocols are available on the https://www.protocols.io platform at the links provided in the Materials and methods section. Prism files, which include all individual values for all tests, detailed statistical analyses, raw and processed images, photometry, sleep recordings, all MATLAB and ImageJ scripts, and behavioral videos, are available at 10.5281/zenodo.10822457. Raw confocal images with file sizes too large to deposit to Zenodo are available upon request to the corresponding authors or (https://weill.cornell.edu/). The data, code, protocols, and key lab materials used and generated in this study are listed in a Key Resources Table alongside their persistent identifiers at 10.5281/zenodo.10822457.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 30 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 12 authors, 5 keywords, 10 MeSH terms, 3 funders, 83 references, 4 RRIDs.

Cite

This paper

Dautan, D., Paslawski, W., Montejo, S. G., Doyon, D. C., Brioschi, V. I., Marongiu, R., Kaplitt, M. G., Chen, R., Dawson, V. L., Zhang, X., Dawson, T. M., & Svenningsson, P. (2026). Gut-initiated alpha synuclein fibrils drive parkinsonism phenotypes: temporal mapping of REM sleep behavior disorder-like and other non-motor symptoms. Translational neurodegeneration, 15(1), 10. https://doi.org/10.1186/s40035-026-00536-6

BibTeX

@article{dautan2026gut,
author = {Dautan, Daniel and Paslawski, Wojciech and Montejo, Sergio G and Doyon, Daniel C and Brioschi, Valentina I and Marongiu, Roberta and Kaplitt, Michael G and Chen, Rong and Dawson, Valina L and Zhang, Xiaoqun and Dawson, Ted M and Svenningsson, Per},
title = {{Gut-initiated alpha synuclein fibrils drive parkinsonism phenotypes: temporal mapping of REM sleep behavior disorder-like and other non-motor symptoms}},
journal = {Translational neurodegeneration},
year = {2026},
month = mar,
volume = {15},
number = {1},
pages = {10},
publisher = {BMC},
issn = {2047-9158},
doi = {10.1186/s40035-026-00536-6},
url = {https://doi.org/10.1186/s40035-026-00536-6},
pmid = {41808195},
pmcid = {PMC12973632}
}

RIS

TY - JOUR
AU - Dautan, Daniel
AU - Paslawski, Wojciech
AU - Montejo, Sergio G
AU - Doyon, Daniel C
AU - Brioschi, Valentina I
AU - Marongiu, Roberta
AU - Kaplitt, Michael G
AU - Chen, Rong
AU - Dawson, Valina L
AU - Zhang, Xiaoqun
AU - Dawson, Ted M
AU - Svenningsson, Per
TI - Gut-initiated alpha synuclein fibrils drive parkinsonism phenotypes: temporal mapping of REM sleep behavior disorder-like and other non-motor symptoms
T2 - Translational neurodegeneration
J2 - Transl Neurodegener
PY - 2026
DA - 2026/03/10
VL - 15
IS - 1
SP - 10
SN - 2047-9158
PB - BMC
DO - 10.1186/s40035-026-00536-6
UR - https://doi.org/10.1186/s40035-026-00536-6
LA - en
ER -

CSL-JSON

{
"id": "10.1186/s40035-026-00536-6",
"type": "article-journal",
"title": "Gut-initiated alpha synuclein fibrils drive parkinsonism phenotypes: temporal mapping of REM sleep behavior disorder-like and other non-motor symptoms",
"container-title": "Translational neurodegeneration",
"author": [
{
"family": "Dautan",
"given": "Daniel"
},
{
"family": "Paslawski",
"given": "Wojciech"
},
{
"family": "Montejo",
"given": "Sergio G"
},
{
"family": "Doyon",
"given": "Daniel C"
},
{
"family": "Brioschi",
"given": "Valentina I"
},
{
"family": "Marongiu",
"given": "Roberta"
},
{
"family": "Kaplitt",
"given": "Michael G"
},
{
"family": "Chen",
"given": "Rong"
},
{
"family": "Dawson",
"given": "Valina L"
},
{
"family": "Zhang",
"given": "Xiaoqun"
},
{
"family": "Dawson",
"given": "Ted M"
},
{
"family": "Svenningsson",
"given": "Per"
}
],
"container-title-short": "Transl Neurodegener",
"volume": "15",
"issue": "1",
"page": "10",
"DOI": "10.1186/s40035-026-00536-6",
"PMID": "41808195",
"PMCID": "PMC12973632",
"ISSN": "2047-9158",
"publisher": "BMC",
"URL": "https://doi.org/10.1186/s40035-026-00536-6",
"language": "en",
"issued": {
"date-parts": [
[
2026,
3,
10
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1016/j.ebiom.2026.106400 [code]
Data-driven trajectories of atrophy explain clinical heterogeneity across Lewy body diseases.
Journal: EBioMedicine
In common: Parkinson's, clinical / translational, 5 references
[2] doi:10.1038/s41531-026-01287-x [code]
Faecalibacterium prausnitzii, depleted in the Parkinson's disease microbiome, improves motor deficits in α-synuclein overexpressing mice.
Journal: NPJ Parkinson's disease
In common: Parkinson's, mouse, 4 references
[3] doi:10.1038/s41467-026-70303-8 [code]
Behavioral screening defines the molecular Parkinsonism-related subgroups in Drosophila.
Journal: Nature communications
In common: Parkinson's, 4 references
[4] doi:10.1038/s41531-026-01360-5 [code]
Hippocampal atrophy in untreated de novo Parkinson's disease with obstructive sleep apnea.
Journal: NPJ Parkinson's disease
In common: sleep disorders, Parkinson's, clinical / translational, 3 references
[5] doi:10.1038/s41531-026-01420-w
Locus coeruleus α-synuclein overexpression induces prodromal Parkinsonian features in mice.
Journal: NPJ Parkinson's disease
In common: Parkinson's, mouse, 3 references
[6] doi:10.1038/s41392-026-02604-9
Gut microbiota modulation via repeated donor fecal transplantation improves motor and gastrointestinal symptoms in drug-naïve Parkinson's disease: a randomized phase 2 trial.
Journal: Signal transduction and targeted therapy
In common: Parkinson's, clinical / translational, 3 references
[7] doi:10.1038/s41380-026-03667-4
Engineering functional ventral midbrain dopaminergic neurons in human organoids through WNT modulation and bioreactor culture.
Journal: Molecular psychiatry
In common: Parkinson's, 3 references
[8] doi:10.1038/s41467-026-71317-y [code]
TNF alpha unmasks enteric malate aspartate shuttle dysfunction bridging Parkinson disease and intestinal inflammation.
Journal: Nature communications
In common: Parkinson's, mouse, 3 references
[9] doi:10.1002/cns.70912
Novel Insights Into the Association Between Parkinson's Disease and Constipation: Role of SHMT2 as a Promising Biomarker.
Journal: CNS neuroscience & therapeutics
In common: Parkinson's, clinical / translational, mouse, 2 references
[10] doi:10.1073/pnas.2619797123 [code]
Selective loss of primary cilia and neurotrophic signaling in G51D α-synuclein mice highlights a common pathway to Parkinson's disease.
Journal: Proceedings of the National Academy of Sciences of the United States of America
In common: Parkinson's, mouse, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.